Edition:
United States

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

106.61USD
21 May 2018
Change (% chg)

$0.68 (+0.64%)
Prev Close
$105.93
Open
$106.78
Day's High
$107.02
Day's Low
$106.21
Volume
69,556
Avg. Vol
99,291
52-wk High
$119.03
52-wk Low
$89.49

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.69
Market Cap(Mil.): $5,030.74
Shares Outstanding(Mil.): 47.91
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 24.59 223.30 32.53
EPS (TTM): 4.31 -- --
ROI: 8.64 -8.07 12.63
ROE: 20.62 -10.87 14.50

BRIEF-Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations

May 10 Charles River Laboratories International Inc:

May 10 2018

BRIEF-Charles River Laboratories Reports Q1 Non-GAAP Earnings Per Share Of $1.38

May 10 Charles River Laboratories International Inc:

May 10 2018

BRIEF-Charles River Laboratories CEO's 2017 Total Compensation Was $12.6 Mln

March 29 Charles River Laboratories International Inc:

Mar 29 2018

BRIEF-Charles River Laboratories Announces Offering Of $500 Mln Of Senior Notes

March 26 Charles River Laboratories International Inc:

Mar 26 2018

BRIEF-Charles River Laboratories Q4 GAAP Loss Per Share $0.63

Feb 13 Charles River Laboratories International Inc:

Feb 13 2018

BRIEF-Charles River Laboratories International Board Size Increases From Ten To Eleven​

Jan 16 Charles River Laboratories International Inc:

Jan 16 2018

BRIEF-Charles River Laboratories Acquires KWS Biotest for GBP 15 Mln

Jan 11 Charles River Laboratories International Inc:

Jan 11 2018

Earnings vs. Estimates